PPIH is a novel diagnostic biomarker associated with immune infiltration in cholangiocarcinoma
Abstract Background Cholangiocarcinoma (CHOL) is the second most common primary liver malignancy, characterized by high aggressiveness and heterogeneity. It is typically diagnosed at an advanced stage, leading to a poor prognosis. Although Peptidyl Proline Isomerase H (PPIH) has been implicated in v...
Saved in:
Main Authors: | Jun Ye, Zhitao Chen, Chuan Zhang, Rui Xie, Haini Chen, Peng Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13607-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary Cholangiocarcinoma of the Liver Presenting as a Complicated Hepatic Cyst: A Diagnostic Challenge
by: Chang Won Ha, et al.
Published: (2025-01-01) -
NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
by: Xuewei Li, et al.
Published: (2025-02-01) -
NT5E (CD73) as a prognostic biomarker and therapeutic target associated with immune infiltration in lung adenocarcinoma
by: Leyan Chen, et al.
Published: (2025-02-01) -
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort
by: Nicolas Adamus, et al.
Published: (2025-02-01) -
Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2
by: Jun Luo, et al.
Published: (2024-06-01)